Alcohol and Immune Response
Immune Activation and Neurodegeneration in HIV Infection and Heavy Drinking
1 other identifier
interventional
76
1 country
1
Brief Summary
This study investigates how alcohol affects the immune system and behavior in healthy adults. The study also will examine how an individual's typical drinking habits may affect the immune system's response to alcohol.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 6, 2018
CompletedFirst Posted
Study publicly available on registry
March 30, 2018
CompletedStudy Start
First participant enrolled
October 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 18, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 18, 2021
CompletedJuly 27, 2021
July 1, 2021
2.7 years
March 6, 2018
July 26, 2021
Conditions
Outcome Measures
Primary Outcomes (4)
Plasma lipopolysaccharide (pg/ml)
Plasma concentration of lipopolysaccharide, measured in picograms/ml
0-4 hours
Plasma lipopolysaccharide binding protein (ng/ml)
Plasma concentration of lipopolysaccharide binding protein, measured in nanograms/ml
0-4 hours
Soluble cluster of differentiation 14 (ng/ml)
Plasma concentration of soluble cluster of differentiation 14, measured in nanograms/ml
0-4 hours
Soluble cluster of differentiation 163 (ng/ml)
Plasma concentration of soluble cluster of differentiation 163, measured in nanograms/ml
0-4 hours
Secondary Outcomes (1)
Response time in ms
0-4 hours
Study Arms (3)
Alcohol, placebo
EXPERIMENTALAlcohol, ethyl - Placebo
Alcohol, low dose
EXPERIMENTALAlcohol, ethyl - Low dose
Alcohol, moderate dose
EXPERIMENTALAlcohol, ethyl - Moderate dose
Interventions
Randomized within-subjects design
Randomized within-subjects design
Eligibility Criteria
You may qualify if:
- Ages 21-55 years
- Able to speak and read English
- Regular use of alcohol
- Weight \> or = to 110 lbs and body mass index (BMI) in the 18.5-30 kg/m2 range
- No self-reported use of drugs
You may not qualify if:
- Currently seeking treatment for alcohol or drug use
- Chronic disease
- Use of certain medications
- GI disorders
- Daily/near-daily use of NSAIDs
- Positive urine test for certain drugs
- History of withdrawal symptoms precipitated by alcohol abstinence
- Clinical Institute Withdrawal Assessment for Alcohol score greater than or equal to 10
- History of seizures
- Current major psychiatric disorder
- History of adverse reaction to standard blood draw
- Inability to abstain from tobacco for 8 hours
- Inability to abstain from cannabis for 48 hours
- Pregnant, breastfeeding, or may become pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Brown Universitylead
Study Sites (1)
Brown University
Providence, Rhode Island, 02912, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Behavioral and Social Sciences
Study Record Dates
First Submitted
March 6, 2018
First Posted
March 30, 2018
Study Start
October 1, 2018
Primary Completion
June 18, 2021
Study Completion
June 18, 2021
Last Updated
July 27, 2021
Record last verified: 2021-07